SCREATE

Cell state · L2

T.CD4_Trm.baseline

4,278 cells in the full atlas (not the displayed sample).

These are the cell-population annotations shown in the SCREATE Cell Browser.

Read trait, study and gene evidence reports for this population →

Explore this population in Cell Browser →

Marker genes

METRNL, CREM, THBS1, MYADM, ATP1B3, TIPARP, PMEPA1, LMNA, FTH1, ANKRD9, ANXA1, CCR9, RGCC, VPS37B, SRGN, ELL2, CXCR3, CD69, RUNX3

Annotation genes

CD69, CXCR3, RUNX3, CREM, ANXA1, TIPARP, PMEPA1, FTH1, SRGN

Annotation rationales

CD69 + RUNX3 program residency and Th1-skewed cytotoxic potential; CXCR3 positions cells at CXCL9/10 inflamed fronts; CCR9 in markers suggests ductal/gut bias. SRGN (granule proteoglycan) and THBS1 imply granule competence and matrix interaction. CREM/TIPARP/PMEPA1 provide AHR/TGF-β feedback brakes; ANXA1/iron handling (FTH1) support resolution and metabolic resilience.

Functional implications

Local sentinels at barriers that: (i) deliver focused cytotoxic/Th1 signals, (ii) recruit/shape myeloid partners, and (iii) protect tissue via TGF-β/AHR/pro-resolving brakes; ideal for quick containment without chronic damage.

Marker and functional descriptions are atlas annotations. Explore gene expression, trait associations and regulatory elements in the interactive browsers; see the browser guide.